AK is right though they did have it listed as early Q4 for the proprietary candidates - so it should be just around the corner ? They are obviously separate releases though.
"Efforts to evaluate the activity of a panel of
proprietary Phylomer Myc hits are continuing.
Candidates are being expressed as proteins
fused to a cell penetrating Phylomer and then
tested for activity when delivered as drugs
into various cancer cell lines. The overall goal
is to identify proprietary leads that function
with equivalent or greater potency than
Omomyc. Results from these studies will be
reported early Q4 2015."
PYC Price at posting:
1.2¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)